{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:28:07Z","timestamp":1787243287760,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.radonc.2008.11.013","type":"journal-article","created":{"date-parts":[[2008,12,27]],"date-time":"2008-12-27T04:08:10Z","timestamp":1230350890000},"page":"232-236","source":"Crossref","is-referenced-by-count":130,"title":["Urethral stricture following high dose rate brachytherapy for prostate cancer"],"prefix":"10.1016","volume":"91","author":[{"given":"Lisa","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keen Hun","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Foroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cleeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.","family":"Duchesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2008.11.013_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(02)02954-1","article-title":"Dose response in prostate cancer with 8\u201312 years\u2019 follow-up","volume":"54","author":"Hanks","year":"2002","journal-title":"Int Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2006.06.002","article-title":"Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer","volume":"176","author":"Zelefsky","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ijrobp.2003.08.003","article-title":"Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer","volume":"58","author":"Galalae","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0360-3016(02)02733-5","article-title":"Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer","volume":"53","author":"Martinez","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(98)00097-2","article-title":"High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report","volume":"41","author":"Mate","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2008.11.013_bib7","first-page":"747","article-title":"What is the alpha\/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy","volume":"44","author":"Duchesne","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2006.12.036","article-title":"Use of individual fraction size data from 3756 patients to directly determine the alpha\/beta ratio of prostate cancer","volume":"68","author":"Williams","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2007.05.019","article-title":"Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I\/II study results","volume":"84","author":"Duchesne","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2008.11.013_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.brachy.2006.08.007","article-title":"A prospective dose escalation trial of high-dose-rate brachytherapy for prostate cancer: evidence for hypofractionation efficacy?","volume":"5","author":"Tang","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2008.11.013_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2004.10.014","article-title":"Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer","volume":"74","author":"\u00c5str\u00f6m","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2008.11.013_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clon.2004.12.005","article-title":"The emerging role of high-dose-rate brachytherapy for prostate cancer","volume":"17","author":"Morton","year":"2005","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2008.11.013_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.eururo.2004.11.014","article-title":"High dose rate brachytherapy with conformal radiation therapy of localized prostate cancer","volume":"47","author":"Deger","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/01.ju.0000052720.62999.a9","article-title":"Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors","volume":"169","author":"Martinez","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/01.ju.0000113260.07979.d3","article-title":"Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer","volume":"171","author":"Pellizzon","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.juro.2006.08.109","article-title":"High dose rate brachytherapy as a boost for the treatment of localized prostate cancer","volume":"177","author":"Phan","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib18","first-page":"135","article-title":"Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation","volume":"6","author":"Vicini","year":"2000","journal-title":"Tech Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","article-title":"Detailed urethral dosimetry in the evaluation of prostate brachytherapy related urinary morbidity","volume":"62","author":"Allen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(05)00681-6","article-title":"Risk factors for the development of prostate brachytherapy related urethral strictures","volume":"175","author":"Merrick","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0360-3016(00)00714-8","article-title":"Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection","volume":"48","author":"Sandhu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X","article-title":"Interstitial iodine125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma","volume":"80","author":"Ragde","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2008.11.013_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0302-2838(02)00016-7","article-title":"High dose rate brachytherapy of localized prostate cancer","volume":"41","author":"Deger","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","article-title":"The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy","volume":"31","author":"Marks","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1464-410X.2004.04550.x","article-title":"Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma","volume":"93","author":"Moreira","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2008.11.013_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/01.ju.0000113260.07979.d3","article-title":"Re: late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer","volume":"171","author":"Pellizzon","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib29","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0360-3016(86)90283-X","article-title":"The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractions","volume":"12","author":"Seymore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1464-410x.1999.00908.x","article-title":"Is transurethral resection of the prostate still justified?","volume":"83","author":"Madersbacher","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2008.11.013_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pros.10339","article-title":"Long-term morbidity and mortality of transurethral prostatectomy: a 10 year follow-up","volume":"58","author":"Varkarakis","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.radonc.2008.11.013_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1634\/theoncologist.7-2-136","article-title":"The effect of non-malignant systemic disease on tolerance to radiation therapy","volume":"7","author":"Chon","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2008.11.013_bib33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ijrobp.2004.06.251","article-title":"Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer","volume":"61","author":"Zaider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0360-3016(99)00477-0","article-title":"Needle displacement during HDR brachytherapy in the treatment of prostate cancer","volume":"46","author":"Damore","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-8140(03)00203-2","article-title":"High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions","volume":"68","author":"Hoskin","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2008.11.013_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(00)01463-2","article-title":"Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favourable stage prostate cancer: a feasibility report","volume":"49","author":"Martinez","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0360-3016(01)01758-8","article-title":"Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalations using high-dose-rate brachytherapy for locally advanced prostate cancer","volume":"52","author":"Galalae","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.11.013_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1464-410X.2005.05908.x","article-title":"Factors predisposing to the development of anastomotic strictures in a single-surgeon series of radical retropubic prostatectomies","volume":"97","author":"Huang","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2008.11.013_bib39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0022-5347(05)67819-6","article-title":"Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy","volume":"163","author":"Kao","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2008.11.013_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0094-0143(02)00031-9","article-title":"Urethral reconstruction of strictures resulting from treatment of benign prostatic hypertrophy and prostate cancer","volume":"29","author":"Santucci","year":"2002","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.radonc.2008.11.013_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0090-4295(00)00539-2","article-title":"Complications after radical retropubic prostatectomy in the Medicare population","volume":"56","author":"Benoit","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2008.11.013_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.juro.2006.09.052","article-title":"Adult anterior urethral strictures: a national practice patterns survey of board certified urologists in the United States","volume":"177","author":"Bullock","year":"2007","journal-title":"J Urol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781400800649X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781400800649X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T14:24:16Z","timestamp":1558016656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781400800649X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S016781400800649X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2008.11.013","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}